Linkevičiūtė, Alma
Ethics and Law: How Artificial Intelligence May Shape Cancer Research During PregnancyItem type:Publication, research article[2025][S1][M001,S001][8]; ; Peccatori, FedroAI in Precision Oncology., 2025, p. 8-15Abstract Background: Historically, pregnant patients have not been included in clinical research, as the risk of damaging the healthy development of the fetus was considered too high. This practice is changing, and the applications of artificial intelligence (AI) to pregnancy research offer a wide range of solutions that are expected to help closing the knowledge gap regarding how best to treat pregnant patients with cancer. The AI tools currently available offer support in screening, diagnosing, treatment planning, and patient counselling. These AI tools, however, were not developed by clinicians or medical researchers; thus, close collaboration between clinicians and the developers of AI tools is urgently needed. Methods: Many of the questions that emerge when AI is used to better approach a pregnant patient with cancer are not technological. Instead, these questions concern value conflicts that cannot be solved by technological tools alone and where wider public debate and agreement are required. How should AI tools consider the developing fetus and its pregnant mother? Should both the pregnant person and the developing fetus be regarded as patients or research participants? What kind of relationship between the two should be incorporated into AI algorithms? This article provides an in-depth interdisciplinary analysis of the above questions and concludes with recommendations for the immediate future. Results: Key recommendations include (1) adhering to existing biomedical ethics principles of respect for patient autonomy, including the relational context; the balance of maternal and fetal beneficence; protection of the vulnerable; and reasonable resource allocation in the given circumstances; (2) when recruiting pregnant patients to research studies, focusing on building pregnant patients’ trust in clinical research and on enhancing pregnant patients’ knowledge so that they feel able to understand and adhere to clinical research requirements; (3) various AI tools can help health care professionals and researchers to plan clinical studies and to create patient- and clinician-directed educational and decision-making tools, while also making them more accessible. Conclusions: Wider cross-disciplinary debate is still needed in order to establish how AI systems and tools for cancer treatment during pregnancy and pregnancy research in general should regard pregnant patients and their developing fetuses, especially where moral status questions are concerned.
11 Guidelines for Cancer Treatment during Pregnancy: Ethics-Related Content Evolution and Implications for CliniciansItem type:Publication, research article[2022][S1][H001][21]; ;Canario, Rita ;Peccatori, Fedro AlessandroDierickx, KrisCancers. [Basel] : MDPI AG, 2022, vol. 14, iss. 17, ARTN 4325., p. 1-21(1) Background: Current scientific evidence suggests that most cancers, including breast cancer, can be treated during pregnancy without compromising maternal and fetal outcomes. This, however, raises questions regarding the ethical implications of clinical care. (2) Methods: Using a systematic literature search, 32 clinical practice guidelines for cancer treatment during pregnancy published between 2002 and 2021 were selected for analysis and 25 of them mentioned or made references to medical ethics when offering clinical management guidance for clinicians. (3) Results: Four bioethical themes were identified: respect for patient’s autonomy, balanced approach to maternal and fetal beneficence, protection of the vulnerable and justice in resource allocation. Most guidelines recommended informing the pregnant patient about available evidence-based treatment options, offering counselling and support in the process of decision making. The relational aspect of a pregnant patient’s autonomy was also recognized and endorsed in a significant number of available guidelines. (4) Conclusions: Recognition and support of a patient’s autonomy and its relational aspects should remain an integral part of future clinical practice guidelines. Nevertheless, a more structured approach is needed when addressing existing and potential ethical issues in clinical practice guidelines for cancer treatment during pregnancy.
15Scopus© Citations 19 The regulatory impact of a harmonized artificial intelligence regulation proposal on the clinical research landscape in the European UnionItem type:Publication, research article[2022][S1][S001][16]; ;Curigliano, Giuseppe ;Peccatori, Fedro AlessandroBioLaw Journal. Trento : University of Trento, 2022, N. 2., p. 509-524This article offers a critical analysis of how the proposed Artificial Intelligence Act (AIA) will support the rights, safety, dignity, and well-being of clinical research participants and ensure the availability of reliable and robust data as described in Clinical Trials Regulation (EU) No. 536/2014. Analysis is focused on how the proposed regulation will impact clinical research conducted within the European Union. The proposed artificial intelligence regulation is evaluated based on what it will bring to the multiple stakeholders in clinical research - including sponsors, investigators, patients, society -and how it would align with the core principles of the Clinical Trials Regulation.
63 24Scopus© Citations 2